ABC01027GH

Olmesartan Impurity 6

Olmesartan Impurity 6 is a process-related byproduct formed during the synthesis of olmesartan medoxomil via amidation of 4’-chlorobiphenyl-2-carboxylic acid. It retains the biphenyl core but lacks the tetrazole ring, featuring instead a substituted pyridine moiety linked through an amide bond. The compound exhibits a hydroxyl group at the 5-position of the pyridine and a methoxy ester functionality, distinguishing it from the parent drug’s angiotensin II receptor antagonist structure. This impurity arises from premature termination of the tetrazole-forming cascade, serving as a key HPLC reference standard for monitoring synthetic pathway efficiency.

On Request
Molecular Formula C11H16N2O3
Molecular Weight 224.2600
CAS Number 144690-07-3 ✓ Verified
PubChem CID 10513320 ↗
Purity N/A
Product Type API Impurity
Parent Drug Olmesartan
Lead Time On Request
IUPAC Name ethyl 4-acetyl-2-propyl-1H-imidazole-5-carboxylate

📝 Synonyms

144690-07-3 ethyl 4-acetyl-2-propyl-1H-imidazole-5-carboxylate Ethyl 5-acetyl-2-propyl-1H-imidazole-4-carboxylate MFCD18910535 5-Acetyl-2-propyl-1H-Imidazole-4-carboxylic Acid Ethyl Ester 1H-Imidazole-4-carboxylic acid, 5-acetyl-2-propyl-, ethyl ester 1H-Imidazole-5-carboxylic acid, 4-acetyl-2-propyl-, ethyl ester 5-Acetyl-2-propyl-3H-imidazole-4-carboxylic acid ethyl ester ethyl 4-acetyl-2-propylimidazole-5-carboxylate Olmesartan Impurity 38

🔬 Chemical Identifiers

CCCC1=NC(=C(N1)C(=O)OCC)C(=O)C
InChI=1S/C11H16N2O3/c1-4-6-8-12-9(7(3)14)10(13-8)11(15)16-5-2/h4-6H2,1-3H3,(H,12,13)
VZPSJLSTXDBKLC-UHFFFAOYSA-N
Quick enquiry on WhatsApp: Ask about this product →
WhatsApp Us